Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

EntreMed

Explore full profile

Pharmaceutical company developing enmd-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer

Rockville, United StatesFounded 1991Biotech & Life Sciences
Valuation $50–100M Last recorded · 2012
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for EntreMed and the history behind them.

At a glance

Status
Operational
Founded
1991
Headquarters
Rockville, United States
Employees
13
Open positions
None listed
Dealroom signal
48.6/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Links
WebsiteLinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Jan 2012 $10M $40M ETP Ventures · Accel —
SPINOUT✓Other financing Jan 1991 $0 — Children’s Hospital Boston · Harvard University —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

EntreMed website traffic

Latest recorded traffic for EntreMed is 590 monthly website visits, down 97.3% over the last three months. EntreMed's team grew 0% over the past year.

Latest monthly visits590 3-month web change-97.3% 1-year team growth0%
Monthly website visitsMay 2017–Jul 2026
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Draig TherapeuticsTargeted neuromodulators for major neuropsychiatric disorders treatment Cardiff, United Kingdom Operational 44 $217M $700M
Solve TherapeuticsTargeted cancer therapies enhancing safety and precision San Diego, United States Operational
AviadoBioPrecision gene therapies for neurodegenerative disorders London, United Kingdom Operational
Teitur TrophicsCyclic peptide therapeutics for neurodegenerative diseases Aarhus, Denmark Operational
PerformsApplies patented nanotechnology to enhance solubility and delivery of an endogenous anti‑inflammatory molecule for psoriasis treatment Modena, Italy Operational
ExeVir BioCamelid-derived antibody therapies for infectious diseases Ghent, Belgium Operational
Nature’s ToolboxNature's Toolbox (NTx) is advancing the healthcare industry with their cutting-edge biomanufacturing solutions Santa Fe, United States Operational
ViaNautis BioPolymer nanoparticle platform for targeted intracellular genetic delivery Cambridge, United Kingdom Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Other known investors2 additional known investors

  • Children’s Hospital Boston
  • Harvard University

Talent

Book a demo to see the people
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Rockville HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about EntreMed on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See EntreMed’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.